Study of Biostate® in Children With Von Willebrand Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Von Willebrand Disease
Interventions
BIOLOGICAL

Biostate

"PK component: Single bolus infusion of 80 IU VWF:RCo/kg administered intravenously on Day 1, and approximately Day 180 in Type 3 VWD subjects only.~Efficacy component: Repeated bolus doses over 12 months as required to manage VWD condition."

Trial Locations (7)

28177

Study site, Bremen

223040

Study site, Minsk

246040

Study site, Homyel

0179

Study site, Tbilisi

01010

Study site, Guatemala City

Unknown

Study site, Beirut

Study Site, Lviv

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Parexel

INDUSTRY

lead

CSL Behring

INDUSTRY